PCM
IDYA icon

Penserra Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Penserra Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-880
Closed -$22K – 1440
2021
Q3 		$22K Buy
880
+130
+17% +$3.04K ﹤0.01% 1228
2021
Q2 		$15K Buy
750
+90
+14% +$1.85K ﹤0.01% 1219
2021
Q1 		$15K Sell
660
-5
-0.8% -$97 ﹤0.01% 994
2020
Q4 		$9K Buy
+665
New +$9.01K ﹤0.01% 932

Other funds holding IDYA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Penserra Capital Management's IDYA Position: Q4 2021 in Review

Penserra Capital Management sold out of IDEAYA Biosciences (IDYA) in Q4 2021, closing a stake of 880 shares — an estimated $22K sold.

Penserra Capital Management first reported a position in IDYA in Q4 2020 and held it in 4 quarters. The position peaked at $22K in Q3 2021. 110 funds tracked by Wall St. Rank hold IDYA as of Q4 2021.

  • Penserra Capital Management reported no remaining IDEAYA Biosciences position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 880 IDEAYA Biosciences shares in Q4 2021, an estimated $22K.
  • Penserra Capital Management first reported a position in IDEAYA Biosciences in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's IDEAYA Biosciences position peaked at $22K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.